Sacituzumab tirumotecan for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Apr 2026: Trial registered, NCT07511023

The trials

NCT07511023: Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

State
Not started
Phase
Phase 2
People
20 planned
Started
25 Sep 2026
Primary completion
1 Mar 2031
Arms
Phase 2: Treatment with Sacituzumab Tirumotecan
Results
None posted
  1. 6 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.